Bank of Montreal
BHVN

Bank of Montreal’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bank of Montreal’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-55,117
Closed -$8.36K – 4614
2022
Q3 		$8.36K Buy
55,117
+10,150
+23% +$1.5M ﹤0.01% 1080
2022
Q2 		$6.51K Buy
+44,967
New +$5.74M ﹤0.01% 1271
2022
Q1 		– Sell
-10,966
Closed -$1.52M – 4423
2021
Q4 		$1.52M Sell
10,966
-3,492
-24% -$444K ﹤0.01% 1729
2021
Q3 		$1.91M Buy
+14,458
New +$1.81M ﹤0.01% 2099
2021
Q2 		– Sell
-1,392
Closed -$98K – 5565
2021
Q1 		$98K Sell
1,392
-6,071
-81% -$491K ﹤0.01% 3408
2020
Q4 		$645K Buy
7,463
+5,229
+234% +$443K ﹤0.01% 2560
2020
Q3 		$155K Sell
2,234
-1,537
-41% -$101K ﹤0.01% 2854
2020
Q2 		$286K Buy
+3,771
New +$201K ﹤0.01% 2553
2020
Q1 		– Sell
-5,267
Closed -$287K – 5144
2019
Q4 		$287K Buy
5,267
+1,537
+41% +$76.1K ﹤0.01% 2966
2019
Q3 		$156K Buy
3,730
+578
+18% +$24.4K ﹤0.01% 3063
2019
Q2 		$138K Buy
3,152
+2,952
+1,476% +$166K ﹤0.01% 3144
2019
Q1 		$10K Sell
200
-404
-67% -$17.5K ﹤0.01% 3893
2018
Q4 		$22K Buy
604
+207
+52% +$7.46K ﹤0.01% 3620
2018
Q3 		$15K Buy
397
+151
+61% +$5.55K ﹤0.01% 3815
2018
Q2 		$10K Buy
+246
New +$7.8K ﹤0.01% 3973
2018
Q1 		– Sell
-91
Closed -$2K – 4543
2017
Q4 		$2K Sell
91
-4,091
-98% -$113K ﹤0.01% 4085
2017
Q3 		$156K Buy
+4,182
New +$127K ﹤0.01% 2769

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Bank of Montreal's BHVN Position: Q4 2022 in Review

Bank of Montreal sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 55,117 shares — an estimated $8.36K sold.

Bank of Montreal first reported a position in BHVN in Q3 2017 and held it in 17 quarters. The position peaked at $1.91M in Q3 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Bank of Montreal reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Bank of Montreal sold 55,117 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $8.36K.
  • Bank of Montreal first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2017 and held it in 17 quarters.
  • Bank of Montreal's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $1.91M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Bank of Montreal's 13F filing for Q4 2022, filed 1 Feb 2023.